
Sign up to save your podcasts
Or


This week we discuss a huge and really important meta-analysis of SGLT-2 inhibitors (flozins) and GLP-1 agonists (tides). Also, a good guideline on Lyme disease diagnosis and treatment, and a novel approach to treating migraine.
By Mark Ebell4.7
9292 ratings
This week we discuss a huge and really important meta-analysis of SGLT-2 inhibitors (flozins) and GLP-1 agonists (tides). Also, a good guideline on Lyme disease diagnosis and treatment, and a novel approach to treating migraine.

137 Listeners

700 Listeners

497 Listeners

288 Listeners

283 Listeners

262 Listeners

3,342 Listeners

1,153 Listeners

194 Listeners

86 Listeners

513 Listeners

365 Listeners

248 Listeners

370 Listeners

314 Listeners